Explore more
News
AstraZeneca, lung cancer
Digest more
The pharmaceutical giant said second-quarter revenue increased to $14.46 billion from $12.94 billion. Revenue in its oncology ...
AstraZeneca share price held steady this week after the company published strong financial results on Tuesday.
AstraZeneca has dropped the lead candidate from its $200 million buyout of Neogene Therapeutics as part of a wider cell ...
The AstraZeneca share price has been treading water for the past few years, but first-half results add strength to rising ...
DPA International on MSN3h
AstraZeneca reports profit jump in second quarter, confirms outlook
Profit and revenue for British-Swedish drug major AstraZeneca were up in the second quarter, the company reported on Tuesday, ...
On a per-share basis, the Cambridge, Britain-based company said it had net income of 79 cents. Earnings, adjusted for non-recurring costs, came to $1.09 per share. The results met Wall Street ...
Barclays today said half-year pre-tax profits rose 23% to £5.2 billion, boosted by a 28% improvement in the second quarter of ...
AstraZeneca’s revenues beat expectations for the second quarter, powered by record growth in its all-important US business.
Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback